Literature DB >> 25589611

Gut Feeling in AKI: The Long Arm of Short-Chain Fatty Acids.

Ian R Barrows1, Ali Ramezani2, Dominic S Raj3.   

Abstract

Entities:  

Keywords:  acute renal failure; gut microbiome; short–chain fatty acids

Mesh：

Substances：

Year:  2015        PMID： 25589611      PMCID： PMC4520177          DOI： 10.1681/ASN.2014111157

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  15 in total

1.  The human microbiome project.

Authors:  Peter J Turnbaugh; Ruth E Ley; Micah Hamady; Claire M Fraser-Liggett; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

2.  Gut Bacteria Products Prevent AKI Induced by Ischemia-Reperfusion.

Authors:  Vinicius Andrade-Oliveira; Mariane T Amano; Matheus Correa-Costa; Angela Castoldi; Raphael J F Felizardo; Danilo C de Almeida; Enio J Bassi; Pedro M Moraes-Vieira; Meire I Hiyane; Andrea C D Rodas; Jean P S Peron; Cristhiane F Aguiar; Marlene A Reis; Willian R Ribeiro; Claudete J Valduga; Rui Curi; Marco Aurelio Ramirez Vinolo; Caroline M Ferreira; Niels Olsen Saraiva Câmara
Journal:  J Am Soc Nephrol       Date:  2015-01-14       Impact factor: 10.121

3.  Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.

Authors:  T Davis; C Kennedy; Y E Chiew; C L Clarke; A deFazio
Journal:  Clin Cancer Res       Date:  2000-11       Impact factor: 12.531

4.  The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition.

Authors:  Pamela V Chang; Liming Hao; Stefan Offermanns; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-03       Impact factor: 11.205

Review 5.  Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides.

Authors:  D L Topping; P M Clifton
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

6.  Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.

Authors:  Emmanuel Le Poul; Cecile Loison; Sofie Struyf; Jean-Yves Springael; Vincent Lannoy; Marie-Eve Decobecq; Stephane Brezillon; Vincent Dupriez; Gilbert Vassart; Jo Van Damme; Marc Parmentier; Michel Detheux
Journal:  J Biol Chem       Date:  2003-04-23       Impact factor: 5.157

Review 7.  The gut microbiome, kidney disease, and targeted interventions.

Authors:  Ali Ramezani; Dominic S Raj
Journal:  J Am Soc Nephrol       Date:  2013-11-14       Impact factor: 10.121

8.  TLR4 activation mediates kidney ischemia/reperfusion injury.

Authors:  Huiling Wu; Gang Chen; Kate R Wyburn; Jianlin Yin; Patrick Bertolino; Josette M Eris; Stephen I Alexander; Alexandra F Sharland; Steven J Chadban
Journal:  J Clin Invest       Date:  2007-10       Impact factor: 14.808

9.  Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury.

Authors:  Hye Ryoun Jang; Maria Teresa Gandolfo; Gang Jee Ko; Shailesh Satpute; Lorraine Racusen; Hamid Rabb
Journal:  Am J Physiol Renal Physiol       Date:  2009-08-12

10.  Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury.

Authors:  Man Jiang; Kebin Liu; Jia Luo; Zheng Dong
Journal:  Am J Pathol       Date:  2010-01-14       Impact factor: 4.307
View more
  7 in total

Review 1.  Chronic kidney disease and the gut microbiome.

Authors:  Gerren P Hobby; Oleg Karaduta; Giuseppina F Dusio; Manisha Singh; Boris L Zybailov; John M Arthur
Journal:  Am J Physiol Renal Physiol       Date:  2019-03-13

Review 2.  Short-Chain Fatty Acids in Chronic Kidney Disease: Focus on Inflammation and Oxidative Stress Regulation.

Authors:  Giorgia Magliocca; Pasquale Mone; Biagio Raffaele Di Iorio; August Heidland; Stefania Marzocco
Journal:  Int J Mol Sci       Date:  2022-05-11       Impact factor: 6.208

Review 3.  Role of the Gut Microbiome in Uremia: A Potential Therapeutic Target.

Authors:  Ali Ramezani; Ziad A Massy; Björn Meijers; Pieter Evenepoel; Raymond Vanholder; Dominic S Raj
Journal:  Am J Kidney Dis       Date:  2015-11-15       Impact factor: 8.860

4.  Oral Co-administration of Soy-derived Extracts with Alcohol or with Sugar-sweetened Beverages Exerts Liver and Sugar Protective Effects.

Authors:  Tawfik Khoury; Devorah Rotnemer-Golinkin; Yehudit Shabat; Lidya Zolotarovya; Yaron Ilan
Journal:  J Clin Transl Hepatol       Date:  2017-06-03

5.  Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review.

Authors:  Jin Zhao; Xiaoxuan Ning; Baojian Liu; Ruijuan Dong; Ming Bai; Shiren Sun
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

6.  Microbiome-Metabolome Signature of Acute Kidney Injury.

Authors:  Nadezda V Andrianova; Vasily A Popkov; Natalia S Klimenko; Alexander V Tyakht; Galina V Baydakova; Olga Y Frolova; Ljubava D Zorova; Irina B Pevzner; Dmitry B Zorov; Egor Y Plotnikov
Journal:  Metabolites       Date:  2020-04-04

Review 7.  The Impact of CKD on Uremic Toxins and Gut Microbiota.

Authors:  Jacek Rysz; Beata Franczyk; Janusz Ławiński; Robert Olszewski; Aleksanda Ciałkowska-Rysz; Anna Gluba-Brzózka
Journal:  Toxins (Basel)       Date:  2021-03-31       Impact factor: 4.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.